ABSTRACT
The field of bioinformatics now depends heavily on AI technology that will modify the current state of medical practices alongside scientific research. The sorting and analysis of large biological data sets benefit from Original Artificial Intelligence and its subcategories including machine learning and deep learning which previously struggled with data interpretation. This review evaluates the fundamental AI enabled bioinformatics approaches with their deployment for genomic and protein structure prediction and drug discovery algorithms and diagnostic solutions. Different AI models demonstrate exceptional ability to identify genetic disease-related mutations and to forecast protein structure in addition to accelerating pharmaceutical research while enhancing diagnosis reliability. Even so various issues related to data quality together with unclear model interpretability and ethical considerations persist. AI-generated bioinformatics continues to form an emerging field that holds transformative potential in the areas of precision medicine together with multiomics analyses and precision health systems. AI technology will continue to evolve in future, thus transforming bioinformatics while solving modern biological and healthcare problems.
KEYWORDS: Artificial intelligence, bioinformatics, deep learning, drug discovery, genomic data, machine learning, personalized medicine, protein structure
INTRODUCTION
During recent decades, bioinformatics evolved as a groundbreaking multidisciplinary field that leads the interpretation and analysis of extensive biological research data. High-throughput technologies generating genomic and proteomic and transcriptomic and metabolomic data sets have driven biological information expansion into complex and extensive levels.[1] The incredible volume and complexity of modern biomedical data sets outpace traditional computational methods which have lost their efficiency in this situation. Bioinformatics developed through combining advanced computational tools with algorithms such as Artificial Intelligence to surmount standard method restrictions. Using AI in bioinformatics enables superior identification of biomarkers and personalized diagnostics and treatment recommendations and increases drug discovery potential. The processing capabilities of machine learning algorithms identify meaningful connections among biological data which results in more accurate healthcare decisions.[2] Deep learning, with its ability to analyze high-dimensional data such as genomic sequences and medical imaging, has enhanced the understanding of diseases at a molecular level and accelerated the development of new therapeutics.[3] The integration of AI into bioinformatics has already had profound effects on healthcare, enabling faster and more precise diagnostic tools, improving patient outcomes through personalized medicine, and speeding up the drug discovery process.[4] The implementation of AI in healthcare systems comes with specific issues regarding data quality management as well as the difficulty of interpreting AI-based decisions together with ethical concerns surrounding AI-driven healthcare.[5] The article discusses AI applications in bioinformatics while exploring specific areas such as predictive modeling and drug development and biomarker discovery. The paper investigates AI’s transformative impact on healthcare and scientific research through its viable answers to the most significant medical challenges of today.
AI IN BIOINFORMATICS: AN OVERVIEW
AI represents multiple methods which enable machines to generate decisions and predictions from specific data collections without specific programming. The use of AI methods including ML, DL, and NLP transforms both data interaction techniques and analytic processes and interpretive capabilities in bioinformatics applications. The combination of AI and biological time series analysis works perfectly because it processes multidimensional data while delivering results which were previously unreachable. Deep learning serves as an ML subfield which applies neural networks spread across multiple layers for automatic data representation learning according to LeCun et al.[6] The application of AI in bioinformatics entails vital operations which involve data preprocessing alongside feature extraction alongside prediction and analysis of large biological data sets that require lengthy processing time or cannot be processed manually.
APPLICATIONS OF AI IN BIOINFORMATICS
Genomic data analysis
Genetic background of disease together with genotype differences can be identified through genome nucleotide sequences. Analysis of genomic data faces significant challenges because current methods were designed for smaller and simpler data sets. The implementation of AI techniques proves to be highly effective for dealing with and understanding this body of knowledge. Machine learning tools predict genetic mutations which affect conditions such as cancer and neurodegenerative diseases and rare illnesses according to Esteva et al.[7] The predictive models enable researchers to determine protein activity effects and disease outcomes for personalized therapy development. Additionally, AI helps review next-generation sequencing data. The massive genomic data created by NGS technologies demand suitable computational tools for analysis purposes. Random forests together with support vector machines operate as ML algorithms to distinguish genomic variants, while deep learning algorithms process gene expression profiles and biomarkers for various diseases.[8] Through the use of AI to analyze enormous genomic data sets, researchers discover previously invisible features along with actual linkages that previously remained hidden.
Protein structure prediction
All living beings rely on proteins as their functional mechanisms, while protein structures reveal necessary information about diseases along with potential treatment solutions. Scientists face extreme difficulty while trying to predict protein three-dimensional conformations starting only from protein amino acid sequences.[9] Recent years have brought substantial progress through artificial intelligence (AI), especially through deep learning and machine learning programs such as AlphaFold. DeepMind developed AlphaFold as their breakthrough solution which accurately determined protein structures during 2021.[10] The deep learning model delivers predictions about protein structure solutions at experimental-level accuracy levels,[10] thus providing advanced capabilities for protein analysis. The quick and trustworthy identification of protein structures shows great promise to modernize drug discovery through finding new protein targets that can modify biological functions to produce new drugs according to Baker and Sali.[11]
Drug discovery and development
Machine learning and deep learning models materially contribute to drug discovery operations because they forecast molecular interactions and evaluate medication formulations alongside candidate evaluation for testing. The established drug discovery approach takes extended periods coupled with massive costs with unsatisfactory outcomes as results. The identification process becomes shorter when AI establishes precise targets within the human body to react with compounds which leads to better drug development.[12] Computational models help forecasts drug candidate-target protein binding interactions as well as calculate drug toxicity while suggesting modifications that improve candidate drug potency. The rational design of new compounds with bioactivity established from their molecular structure is made possible through deep learning strategies.[13] AI systems enable researchers to secure money-saving time advantages to advance their new drug candidates toward clinical development.
Medical diagnostics
The processing of medical data shows remarkable capabilities through diagnostic image application using AI technology. Researchers present increasing utilization of deep learning technology for analyzing diagnostic examinations X-rays along with CT scans and MRIs which helps medical professionals identify diseases such as cancers and pneumonia and neurological disorders. Axial imaging patterns get analyzed by AI algorithms for radiologists who use the findings to make accurate diagnoses in shorter periods.[14] The detection of biomarkers which predict disease development such as heart and Alzheimer’s diseases can be achieved by applying machine learning algorithms to whole-genome sequence data.[15] Artificial intelligence–based healthcare diagnostics have become essential for personalized medicine through their capability of helping medical practitioners customize therapeutic products based on patients’ genetic makeup.
CHALLENGES AND LIMITATIONS
Multiple obstacles exist before AI can properly function in bioinformatics. Quality along with availability stands as one of the primary obstacles for bioinformatics applications. The real-world biological data contain more noise along with incomplete data as well as varied structural elements when compared with artificial data used for AI modeling. In addition, AI models depend on large annotated data for model training, while such data are often scarce in most cases due to limited availability of rare diseases or newly discovered biological processes.[16] The second concern is the ability to interpret of the AI models that outcome from those AI models especially the deep learning systems are known as ‘black boxes’ since the actual mechanisms applied to the models to make conclusions are not comprehensible to human beings. The lack of clear explanations about AI models places restrictions on their clinical application, particularly when different stakeholders need full understanding of the results.[17] New attention has built up in explainable artificial intelligence or XAI to resolve this challenge. XAI delivers understandable explanations to users about decisions made by the system. In addition, the equation needs to incorporate ethical concerns regarding data safety and algorithm bias and privacy. The significance of privacy protection combined with regulatory compliance becomes vital for both biological and medical AI career fields since these domains heavily rely on personal information. AI algorithms used in practice have demonstrated the capacity to increase existing biases in training data which produces flawed and discriminatory recommendations that might cause problems for patient care management.[18]
FUTURE DIRECTIONS
Thus, the prospects of employing AI in bioinformatics, to come in the future, are tremendous. However, there are few studies in the meta-omics data that include genomics, transcriptomics, proteomics, and other meta data types. Multiple modality data techniques, especially deep learning, could help to combine and analyze these heterogeneous data to improve the understanding of complex biological systems and diseases.[19] Further, AI can be used in discovering new targets for drug intervention since the molecular interactions are multilayered and understanding how one layer modulates the other is possible through computer models. The other promising application domain for AI in bioinformatics is an emerging AI-powered tools for precision medicine. Automated processes in AI could pull together disperse clinical and genetic data to find out optimal treatment approaches, responses to medication, and potential drug dosing for patients. AI can also improve clinical trial design, in particular, by screening good candidates and estimating the patient’s response to certain treatments.[20]
CONCLUSION
The combination of artificial intelligence with bioinformatics research produces a fresh healthcare and scientific period which enhances our comprehension of intricate biological systems for treatment purposes. The implementation of machine learning algorithms with deep learning techniques within bioinformatics supports extraordinary advancements throughout personalized medicine along with disease prediction along with drug discovery and protein structure prediction.[1,2] Protein structure prediction received a breakthrough from AlphaFold through artificial intelligence technology which generated accurate predictions that required extensive experimental methods before their discovery.[10] The new breakthroughs in targeted therapies and diagnostics and optimized treatment planning will establish more effective individualized healthcare.[3,11] The future of AI in bioinformatics seems very promising despite ongoing challenges to achieve high-quality data and resolve ethical questions and improve AI model interpretations.[4] AI shows promising potential to transform healthcare into proactive healthcare alongside personalized medicine and universal access to services and simultaneously accelerate medical discoveries about human biology and disease.[1]
As AI tools become more integrated into clinical and research settings, their impact on improving patient outcomes and advancing scientific knowledge will be transformative, paving the way for groundbreaking solutions in both healthcare and science. In conclusion, AI is not just reshaping bioinformatics; it is laying the foundation for a more precise and efficient future in medicine and biological research, where innovative treatments and solutions are driven by the insights gleaned from complex data.[3,4]
Author contributions
SNT and AAA: Concepts, design, definition of intellectual content, literature search, data acquisition, data analysis, manuscript preparation, manuscript editing, manuscript review, guarantor.
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
REFERENCES
- 1.Dey L, Das A, Ghosh D. Bioinformatics and computational biology in healthcare: A review. J Healthcare Eng 2020. 2020:1–16. [Google Scholar]
- 2.Gulbahar MR, Yilmaz AT, Orak B. Machine learning in bioinformatics: Applications, challenges, and opportunities. Comput Biol Chem. 2021;89:107405. [Google Scholar]
- 3.Ching T, Himmelstein DS, Beaulieu-Jones BK, Kalinin AA, Do BT, Way GP, et al. Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018;15:20170387. doi: 10.1098/rsif.2017.0387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li S, Xu J, Zhang Y. Artificial intelligence in the development of precision medicine for cancer. Cancers. 2020;12:952. [Google Scholar]
- 5.Bini SA. Machine learning in healthcare: Are we ready for it? J Med Internet Res. 2020;22:e17480. [Google Scholar]
- 6.LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44. doi: 10.1038/nature14539. https://doi.org/10.1038/nature14539. [DOI] [PubMed] [Google Scholar]
- 7.Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2019;542:115–8. doi: 10.1038/nature21056. doi: 10.1038/nature21056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cai L, Yoon CH, Kim H. Machine learning in bioinformatics: A practical guide. Bioinformatics. 2017;33:1635–42. [Google Scholar]
- 9.Jones DT. Protein structure prediction in the era of AI. Nat Rev Mol Cell Biol. 2020;21:661–78. [Google Scholar]
- 10.Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–9. doi: 10.1038/s41586-021-03819-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Baker D, Sali A. Protein structure prediction and its impact on drug discovery. Curr Opin Struct Biol. 2021;71:1–8. [Google Scholar]
- 12.Wang X, Zheng X, Yan J. Artificial intelligence in drug discovery. J Med Chem. 2020;63:10621–45. doi: 10.1021/acs.jmedchem.0c01077. [DOI] [PubMed] [Google Scholar]
- 13.Schneider G, Fechner U. Deep learning in drug discovery. Front Artif Intell. 2019;2:1–10. [Google Scholar]
- 14.Litjens G, Kooi T, Bejnordi BE, Setio AA, Ciompi F, Ghafoorian M, et al. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60–88. doi: 10.1016/j.media.2017.07.005. doi: 10.1016/j.media.2017.07.005. [DOI] [PubMed] [Google Scholar]
- 15.Wang S, He K, Lin L. Artificial intelligence in the early diagnosis of disease and in predicting patient outcomes. J Am Med Assoc. 2021;325:122–30. [Google Scholar]
- 16.Kouvaris JR, Tolia VM, Waszak SM. Challenges and opportunities in the application of AI for precision medicine. Front Artif Intell. 2021;4:670073. [Google Scholar]
- 17.Caruana R, Gehrke J, Koch P, Sturm M, Elhadad N. Intelligible models for healthcare: Predicting pneumonia risk and hospital 30-day readmission. Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2015:1721–30. [Google Scholar]
- 18.Obermeyer Z, Powers BW, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366:447–53. doi: 10.1126/science.aax2342. [DOI] [PubMed] [Google Scholar]
- 19.Sharma A, Sharma N, Ghosh M. Applications of artificial intelligence in bioinformatics and healthcare. Bioinform Biol Insights. 2020;14:1177932219895104. [Google Scholar]
- 20.Aliper A, Plis S, Artemov A, Zhavoronkov A. Deep learning applications for predicting pharmacological properties of drugs. Future Med Chem. 2016;8:1625–32. doi: 10.1021/acs.molpharmaceut.6b00248. [DOI] [PMC free article] [PubMed] [Google Scholar]
